• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微生理尿毒症模型揭示血管功能障碍的生物物理增强剂。

Microphysiological Uremia Model Reveals Biophysical Potentiators of Vascular Dysfunction.

作者信息

Rathod Mitesh, Stack Ryan N, Kubik Sarah E, Huang Stephanie A, Whitworth Chloe P, Aw Wen Y, Doherty Elizabeth L, Meehan Sara M, Roy-Chaudhury Prabir, Polacheck William J

机构信息

Lampe Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, 10010 Mary Ellen Jones Building, 116 Manning Drive, Chapel Hill, NC, 27514, USA.

Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill School of Medicine, 130 Mason Farm Road, Chapel Hill, NC, 27599, USA.

出版信息

Adv Sci (Weinh). 2025 Sep;12(33):e17091. doi: 10.1002/advs.202417091. Epub 2025 Jun 20.

DOI:10.1002/advs.202417091
PMID:40538277
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12412532/
Abstract

Cardiovascular disease is a leading cause of mortality in individuals with chronic kidney disease (CKD), with hypertension being a major contributor to both kidney damage and increased cardiovascular risk. Despite the established link between CKD and cardiovascular disease, the role of uremic toxins in monocyte-endothelial interactions under hypertensive conditions remains underexplored. Here, a 3D microfluidic model is developed to examine the effects of indoxyl sulfate on monocyte adhesion and extravasation across engineered microvessels embedded in hydrogels with different densities under controlled luminal pressure. Elevated pressure alone in absence of indoxyl sulfate significantly enhanced monocyte adhesion and extravasation, regardless of matrix density, while matrix density regulated adhesion and transmigration in the uremic environment. ICAM-1 is identified as a key driver of THP-1 monocyte adhesion to the endothelium. Additionally, denser hydrogels primed monocytes toward a pro-inflammatory phenotype with reduced phagocytic capacity, while softer hydrogels induced an anti-inflammatory-like phenotype with enhanced phagocytosis. However, the uremic environment reduced phagocytosis and shifted cells toward a pro-inflammatory-like state, irrespective of matrix density. This approach has the potential to dissect multiple factors that contribute to elevated cardiovascular risks in CKD patients and improve the understanding of mechanisms involved in monocyte dynamics in CKD-related cardiovascular disease.

摘要

心血管疾病是慢性肾脏病(CKD)患者死亡的主要原因,高血压是导致肾脏损害和心血管风险增加的主要因素。尽管CKD与心血管疾病之间的联系已得到证实,但尿毒症毒素在高血压条件下单核细胞与内皮细胞相互作用中的作用仍未得到充分研究。在此,开发了一种三维微流控模型,以研究硫酸吲哚酚对在受控管腔内压力下嵌入不同密度水凝胶中的工程化微血管上单核细胞黏附和渗出的影响。在不存在硫酸吲哚酚的情况下,仅压力升高就显著增强了单核细胞的黏附和渗出,而与基质密度无关,而基质密度在尿毒症环境中调节黏附和迁移。ICAM-1被确定为THP-1单核细胞黏附于内皮的关键驱动因素。此外,密度较高的水凝胶使单核细胞向促炎表型转变,吞噬能力降低,而较软的水凝胶诱导出具有增强吞噬作用的抗炎样表型。然而,尿毒症环境降低了吞噬作用,并使细胞向促炎样状态转变,而与基质密度无关。这种方法有可能剖析导致CKD患者心血管风险升高的多种因素,并增进对CKD相关心血管疾病中单核细胞动态变化所涉及机制的理解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a36a/12412532/8d7e2387bc06/ADVS-12-e17091-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a36a/12412532/26855a5b76c1/ADVS-12-e17091-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a36a/12412532/e3c30a14b728/ADVS-12-e17091-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a36a/12412532/78ff4d483c53/ADVS-12-e17091-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a36a/12412532/044de7cc161b/ADVS-12-e17091-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a36a/12412532/6f3f3bbfd4b0/ADVS-12-e17091-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a36a/12412532/8d7e2387bc06/ADVS-12-e17091-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a36a/12412532/26855a5b76c1/ADVS-12-e17091-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a36a/12412532/e3c30a14b728/ADVS-12-e17091-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a36a/12412532/78ff4d483c53/ADVS-12-e17091-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a36a/12412532/044de7cc161b/ADVS-12-e17091-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a36a/12412532/6f3f3bbfd4b0/ADVS-12-e17091-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a36a/12412532/8d7e2387bc06/ADVS-12-e17091-g001.jpg

相似文献

1
Microphysiological Uremia Model Reveals Biophysical Potentiators of Vascular Dysfunction.微生理尿毒症模型揭示血管功能障碍的生物物理增强剂。
Adv Sci (Weinh). 2025 Sep;12(33):e17091. doi: 10.1002/advs.202417091. Epub 2025 Jun 20.
2
Renal Denervation Improves Uremic Cardiomyopathy in Rats With Chronic Kidney Disease.肾去神经支配改善慢性肾脏病大鼠的尿毒症心肌病
J Am Heart Assoc. 2025 Aug 5;14(15):e038785. doi: 10.1161/JAHA.124.038785. Epub 2025 Jul 21.
3
The role of uremic toxin indoxyl sulfate in the pathophysiology of aortic valve stenosis.尿毒症毒素硫酸吲哚酚在主动脉瓣狭窄病理生理学中的作用。
Cardiovasc Res. 2025 Jun 17. doi: 10.1093/cvr/cvaf106.
4
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
5
GUT-DERIVED UREMIC TOXICITY IN LIONS () WITH CHRONIC KIDNEY DISEASE: A POTENTIAL THERAPEUTIC TARGET?患有慢性肾病的狮子的肠道源性尿毒症毒性:一个潜在的治疗靶点?
J Zoo Wildl Med. 2025 Jun;56(2):258-271. doi: 10.1638/2024-0094.
6
The Non-Traditional Cardiovascular Culprits in Chronic Kidney Disease: Mineral Imbalance and Uremic Toxin Accumulation.慢性肾脏病中非传统的心血管致病因素:矿物质失衡与尿毒症毒素蓄积
Int J Mol Sci. 2025 Aug 17;26(16):7938. doi: 10.3390/ijms26167938.
7
Gut alterations in a chronic kidney disease rat model with diet-induced vascular calcification.饮食诱导血管钙化的慢性肾病大鼠模型中的肠道改变
FEBS Open Bio. 2025 Aug;15(8):1219-1231. doi: 10.1002/2211-5463.70043. Epub 2025 Jun 17.
8
Synbiotics, prebiotics and probiotics for people with chronic kidney disease.慢性肾脏病患者的合生菌、益生元和益生菌。
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD013631. doi: 10.1002/14651858.CD013631.pub2.
9
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.早期转介策略在管理有肾脏疾病标志物的人群中的应用:对临床有效性、成本效益和经济分析证据的系统评价。
Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210.
10
Multiomic Analysis of Calf Muscle in Peripheral Artery Disease and Chronic Kidney Disease.外周动脉疾病和慢性肾脏病中小腿肌肉的多组学分析
Circ Res. 2025 Mar 28;136(7):688-703. doi: 10.1161/CIRCRESAHA.124.325642. Epub 2025 Feb 18.

本文引用的文献

1
Donor-Derived Engineered Microvessels for Cardiovascular Risk Stratification of Patients with Kidney Failure.供体衍生工程微血管用于肾衰竭患者的心血管风险分层。
Small. 2024 Jun;20(24):e2307901. doi: 10.1002/smll.202307901. Epub 2024 Jan 7.
2
Uremic Toxins Induce THP-1 Monocyte Endothelial Adhesion and Migration through Specific miRNA Expression.尿毒症毒素通过特定 miRNA 表达诱导 THP-1 单核细胞内皮黏附和迁移。
Int J Mol Sci. 2023 Aug 18;24(16):12938. doi: 10.3390/ijms241612938.
3
Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease.
慢性肾脏病患者的心血管疾病流行病学和风险。
Nat Rev Nephrol. 2022 Nov;18(11):696-707. doi: 10.1038/s41581-022-00616-6. Epub 2022 Sep 14.
4
Indoxyl sulfate- and P-cresol-induced monocyte adhesion and migration is mediated by integrin-linked kinase-dependent podosome formation.硫酸吲哚酚和对甲酚诱导的单核细胞黏附和迁移是由整合素连接激酶依赖性的足突形成介导的。
Exp Mol Med. 2022 Mar;54(3):226-238. doi: 10.1038/s12276-022-00738-8. Epub 2022 Mar 4.
5
Expanded Hemodialysis Therapy Ameliorates Uremia-Induced Systemic Microinflammation and Endothelial Dysfunction by Modulating VEGF, TNF-α and AP-1 Signaling.扩充性血液透析疗法通过调节 VEGF、TNF-α 和 AP-1 信号改善尿毒症引起的全身微炎症和内皮功能障碍。
Front Immunol. 2021 Nov 11;12:774052. doi: 10.3389/fimmu.2021.774052. eCollection 2021.
6
Microfluidic model of monocyte extravasation reveals the role of hemodynamics and subendothelial matrix mechanics in regulating endothelial integrity.单核细胞渗出的微流控模型揭示了血流动力学和内皮下基质力学在调节内皮完整性中的作用。
Biomicrofluidics. 2021 Sep 14;15(5):054102. doi: 10.1063/5.0061997. eCollection 2021 Sep.
7
Two-Week Burden of Arrhythmias across CKD Severity in a Large Community-Based Cohort: The ARIC Study.在一个大型社区队列中,根据 CKD 严重程度评估心律失常的两周负担:ARIC 研究。
J Am Soc Nephrol. 2021 Mar;32(3):629-638. doi: 10.1681/ASN.2020030301. Epub 2021 Jan 28.
8
Control of Matrix Stiffness Using Methacrylate-Gelatin Hydrogels for a Macrophage-Mediated Inflammatory Response.利用甲基丙烯酰化明胶水凝胶控制基质硬度以调节巨噬细胞介导的炎症反应。
ACS Biomater Sci Eng. 2020 May 11;6(5):3091-3102. doi: 10.1021/acsbiomaterials.0c00295. Epub 2020 Apr 6.
9
Plasminogen activator inhibitor-1 reduces cardiac fibrosis and promotes M2 macrophage polarization in inflammatory cardiomyopathy.纤溶酶原激活物抑制剂-1 可减少炎症性心肌病中的心肌纤维化并促进 M2 巨噬细胞极化。
Basic Res Cardiol. 2021 Jan 11;116(1):1. doi: 10.1007/s00395-020-00840-w.
10
The current and future landscape of dialysis.当前和未来的透析领域。
Nat Rev Nephrol. 2020 Oct;16(10):573-585. doi: 10.1038/s41581-020-0315-4. Epub 2020 Jul 30.